Serum Concentration of the Phytohormone Abscisic Acid Is Associated With Immune-Regulatory Mediators and Is a Potential Biomarker of Disease Severity in Chronic Obstructive Pulmonary Disease.

COPD LanCL2 PPAR-γ abscisic acid asthma

Journal

Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047

Informations de publication

Date de publication:
2021
Historique:
received: 04 03 2021
accepted: 26 04 2021
entrez: 25 6 2021
pubmed: 26 6 2021
medline: 26 6 2021
Statut: epublish

Résumé

COPD and asthma are two distinct but sometimes overlapping diseases exhibiting varying degrees and types of inflammation on different stages of the disease. Although several biomarkers are defined to estimate the inflammatory endotype and stages in these diseases, there is still a need for new markers and potential therapeutic targets. We investigated the levels of a phytohormone, abscisic acid (ABA) and its receptor, LANCL2, in COPD patients and asthmatics. In addition, PPAR-γ that is activated by ABA in a ligand-binding domain-independent manner was also included in the study. In this study, we correlated ABA with COPD-propagating factors to define the possible role of ABA, in terms of immune regulation, inflammation, and disease stages. We collected blood from 101 COPD patients, 52 asthmatics, and 57 controls. Bronchoscopy was performed on five COPD patients and 29 controls. We employed (i) liquid chromatography-tandem mass spectrometry and HPLC to determine the ABA and indoleamine 2,3-dioxygenase levels, respectively; (ii) real-time PCR to quantify the gene expression of LANCL2 and PPAR-γ; (iii) Flow cytometry to quantify adipocytokines; and (iv) immunoturbidimetry and ELISA to measure CRP and cytokines, respectively. Finally, a multinomial regression model was used to predict the probability of using ABA as a biomarker. Blood ABA levels were significantly reduced in COPD patients and asthmatics compared to age- and gender-matched normal controls. However, PPAR-γ was elevated in COPD patients. Intriguingly, ABA was positively correlated with immune-regulatory factors and was negatively correlated with inflammatory markers, in COPD. Of note, ABA was increased in advanced COPD stages. We thereby conclude that ABA might be involved in regulation of COPD pathogenesis and might be regarded as a potential biomarker for COPD stages.

Identifiants

pubmed: 34169084
doi: 10.3389/fmed.2021.676058
pmc: PMC8217626
doi:

Types de publication

Journal Article

Langues

eng

Pagination

676058

Informations de copyright

Copyright © 2021 Hoang, Nguyen, Oberacher, Fuchs, Hernandez-Vargas, Borucki, Waldburg, Wippermann, Schreiber, Bruder and Veluswamy.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Ann Glob Health. 2019 Jan 22;85(1):
pubmed: 30741502
N Engl J Med. 2011 Oct 27;365(17):1567-75
pubmed: 22029978
Curr Opin Pulm Med. 2013 Mar;19(2):95-102
pubmed: 23325031
Plant Cell. 2004 Dec;16(12):3460-79
pubmed: 15548743
Thorax. 2019 May;74(5):439-446
pubmed: 30617161
Medicina (Kaunas). 2020 Aug 28;56(9):
pubmed: 32872366
J Nutr Biochem. 2008 Apr;19(4):216-28
pubmed: 17618105
Mediators Inflamm. 2010;2010:173498
pubmed: 21197447
Am J Physiol Lung Cell Mol Physiol. 2012 Apr 1;302(7):L679-87
pubmed: 22268120
J Endocr Soc. 2018 Dec 21;3(2):403-410
pubmed: 30746502
Lancet. 1982 Sep 25;2(8300):675-8
pubmed: 6126624
Lancet Respir Med. 2020 Jun;8(6):585-596
pubmed: 32526187
FASEB J. 2012 Mar;26(3):1251-60
pubmed: 22075645
Tissue Antigens. 2006 Jan;67(1):57-60
pubmed: 16451202
Clin Chem. 1997 Dec;43(12):2424-6
pubmed: 9439467
Eur Respir J. 2010 Nov;36(5):1034-41
pubmed: 20378599
Rheumatology (Oxford). 2005 Aug;44(8):989-94
pubmed: 15870153
Nat Med. 2019 Nov;25(11):1739-1747
pubmed: 31700183
Proc Am Thorac Soc. 2006 Aug;3(6):503-10
pubmed: 16921129
Front Immunol. 2018 May 08;9:893
pubmed: 29867927
J Nutr Biochem. 2010 Dec;21(12):1178-85
pubmed: 20092994
Chest. 2019 Jan;155(1):168-177
pubmed: 30077690
Int J Chron Obstruct Pulmon Dis. 2020 Mar 31;15:681-690
pubmed: 32280207
Nutrients. 2018 Oct 12;10(10):
pubmed: 30322104
Sci Rep. 2016 Apr 15;6:24548
pubmed: 27079168
Pediatr Pulmonol. 2006 Jul;41(7):674-82
pubmed: 16703581
J Biol Chem. 2009 Oct 9;284(41):28045-28057
pubmed: 19667068
Trends Immunol. 2013 Mar;34(3):137-43
pubmed: 23103127
PLoS One. 2018 Jan 5;13(1):e0190863
pubmed: 29304075
Thorax. 2009 Dec;64(12):1019-24
pubmed: 19736178
Clin Chem. 2002 Mar;48(3):579-81
pubmed: 11861457
Eur Radiol. 2020 May;30(5):2502-2512
pubmed: 31965260
Chest. 1994 Dec;106(6):1730-9
pubmed: 7988192
Thorax. 2015 May;70(5):482-9
pubmed: 25739910
Am J Respir Crit Care Med. 2019 Sep 1;200(5):556-564
pubmed: 30860857
Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):5759-64
pubmed: 17389374
Clin Nutr. 2010 Dec;29(6):824-31
pubmed: 20236740
J Biol Chem. 2011 Jan 28;286(4):2504-16
pubmed: 21088297
Am J Respir Crit Care Med. 2016 Mar 15;193(6):662-72
pubmed: 26695373
J Intern Med. 2007 Apr;261(4):399-407
pubmed: 17391115
Nat Protoc. 2008;3(6):1101-8
pubmed: 18546601
Ann Am Thorac Soc. 2015 Jul;12(7):1005-12
pubmed: 26010877
Proc Natl Acad Sci U S A. 1986 Feb;83(4):1155-8
pubmed: 2937056
Nature. 2006 Jan 19;439(7074):277-8
pubmed: 16421556
Cell. 2014 Jul 3;158(1):41-53
pubmed: 24995977
Curr Drug Metab. 2007 Apr;8(3):237-44
pubmed: 17430112
Lupus. 2017 Oct;26(12):1318-1327
pubmed: 28457196
Allergy. 2017 Feb;72(2):207-220
pubmed: 27775836
J Biol Chem. 2009 Jun 26;284(26):17808-18
pubmed: 19332545
N Engl J Med. 1968 Jun 20;278(25):1355-60
pubmed: 5650164
Cleve Clin J Med. 2020 Aug 31;87(9):569-575
pubmed: 32868307
Allergy Asthma Proc. 2019 Nov 1;40(6):385-388
pubmed: 31690376
Sci Rep. 2020 Jul 16;10(1):11700
pubmed: 32678181
Yonsei Med J. 2019 May;60(5):407-413
pubmed: 31016901
Diabetes. 2007 Jan;56(1):72-9
pubmed: 17192467
J Nutr Biochem. 2011 Sep;22(9):812-9
pubmed: 21109419
Lancet Respir Med. 2017 Sep;5(9):691-706
pubmed: 28822787
Clin Nutr. 2007 Feb;26(1):107-16
pubmed: 17000034
Front Plant Sci. 2016 Feb 19;7:181
pubmed: 26925086
JAMA. 2012 Sep 26;308(12):1254-63
pubmed: 23011715
J Leukoc Biol. 2004 Mar;75(3):478-85
pubmed: 14657213
Am Rev Respir Dis. 1986 Nov;134(5):1011-9
pubmed: 3777663
Thorax. 2008 Dec;63(12):1110-7
pubmed: 19020276
Exp Mol Med. 2017 Aug 4;49(8):e364
pubmed: 28775365
PLoS One. 2015 Feb 27;10(2):e0115992
pubmed: 25723556
Lancet. 2018 Feb 24;391(10122):783-800
pubmed: 29273246
Chest. 2005 Oct;128(4):2035-42
pubmed: 16236852
JAMA. 1994 Nov 16;272(19):1497-505
pubmed: 7966841
Clin Chim Acta. 2006 Feb;364(1-2):82-90
pubmed: 16139256
Biochem Biophys Res Commun. 2011 Nov 18;415(2):390-5
pubmed: 22037458
Thorax. 2013 Apr;68(4):330-7
pubmed: 23255616
Front Pediatr. 2019 Jun 25;7:256
pubmed: 31294006
J Allergy Clin Immunol. 2008 Jan;121(1):43-50
pubmed: 18036645
J Physiol Pharmacol. 2008 Dec;59 Suppl 6:303-9
pubmed: 19218654
J Nutr Biochem. 2013 Jun;24(6):1019-27
pubmed: 22995385
Curr Med Chem. 2016;23(15):1549-70
pubmed: 27048335
Front Endocrinol (Lausanne). 2016 Sep 21;7:128
pubmed: 27708617
Pneumologie. 2017 Dec;71(12):849-919
pubmed: 29216678
Eur Respir J. 2019 Aug 29;54(2):
pubmed: 31273040
COPD. 2018 Feb;15(1):21-26
pubmed: 29161163
Ann N Y Acad Sci. 2000 Jun;908:244-54
pubmed: 10911963
Respir Med. 2014 Jan;108(1):122-8
pubmed: 24135487
Lancet. 2011 Sep 10;378(9795):1015-26
pubmed: 21907865
Circulation. 2000 Sep 12;102(11):1296-301
pubmed: 10982546
Int J Clin Pharmacol Ther. 2014 Nov;52(11):1012-6
pubmed: 25161156
Biochem Biophys Res Commun. 2012 May 25;422(1):70-4
pubmed: 22560900
Plant Physiol. 2003 Dec;133(4):1755-67
pubmed: 14645724

Auteurs

Quynh Trang Mi Hoang (QTM)

Department of Pneumonology, Otto-von-Guericke-University Magdeburg, University Hospital, Magdeburg, Germany.
Infection Immunology Group, Institute of Medical Microbiology and Hospital Hygiene, Health Campus Immunology, Infectiology and Inflammation, Otto-von-Guericke University Hospital, Magdeburg, Germany.

Van Kinh Nguyen (VK)

Department of Infectious Diseases Epidemiology, Imperial College, London, United Kingdom.

Herbert Oberacher (H)

Institute of Legal Medicine and Core Facility Metabolomics, Medical University of Innsbruck, Innsbruck, Austria.

Dietmar Fuchs (D)

Institute of Biological Chemistry, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.

Esteban A Hernandez-Vargas (EA)

Systems Medicine for Infectious Diseases, Frankfurt Institute for Advanced Studies, Frankfurt, Germany.
Instituto de Matematicas, Universidad Nacional Autónoma de México (UNAM), Queretaro, Mexico.

Katrin Borucki (K)

Institute of Clinical Chemistry and Pathobiochemistry, Otto-von-Guericke University, Magdeburg, Germany.

Nadine Waldburg (N)

Ambulatory Pneumology Care, Magdeburg, Germany.

Jens Wippermann (J)

Heart Surgery Research, Department of Cardiothoracic Surgery, Otto-von-Guericke University Hospital, Magdeburg, Germany.

Jens Schreiber (J)

Department of Pneumonology, Otto-von-Guericke-University Magdeburg, University Hospital, Magdeburg, Germany.

Dunja Bruder (D)

Infection Immunology Group, Institute of Medical Microbiology and Hospital Hygiene, Health Campus Immunology, Infectiology and Inflammation, Otto-von-Guericke University Hospital, Magdeburg, Germany.
Immune Regulation Group, Helmholtz Center for Infection Research, Braunschweig, Germany.

Priya Veluswamy (P)

Infection Immunology Group, Institute of Medical Microbiology and Hospital Hygiene, Health Campus Immunology, Infectiology and Inflammation, Otto-von-Guericke University Hospital, Magdeburg, Germany.
Heart Surgery Research, Department of Cardiothoracic Surgery, Otto-von-Guericke University Hospital, Magdeburg, Germany.

Classifications MeSH